PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KALV vs. SMH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between KALV and SMH is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

KALV vs. SMH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KalVista Pharmaceuticals, Inc. (KALV) and VanEck Vectors Semiconductor ETF (SMH). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-21.89%
3.75%
KALV
SMH

Key characteristics

Sharpe Ratio

KALV:

-0.53

SMH:

0.74

Sortino Ratio

KALV:

-0.53

SMH:

1.16

Omega Ratio

KALV:

0.94

SMH:

1.15

Calmar Ratio

KALV:

-0.34

SMH:

1.07

Martin Ratio

KALV:

-1.16

SMH:

2.46

Ulcer Index

KALV:

27.59%

SMH:

10.79%

Daily Std Dev

KALV:

60.64%

SMH:

36.29%

Max Drawdown

KALV:

-96.68%

SMH:

-83.29%

Current Drawdown

KALV:

-92.27%

SMH:

-8.50%

Returns By Period

In the year-to-date period, KALV achieves a 15.47% return, which is significantly higher than SMH's 5.80% return.


KALV

YTD

15.47%

1M

17.83%

6M

-21.85%

1Y

-34.19%

5Y*

-7.15%

10Y*

N/A

SMH

YTD

5.80%

1M

-0.79%

6M

3.75%

1Y

27.56%

5Y*

28.88%

10Y*

26.10%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KALV vs. SMH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KALV
The Risk-Adjusted Performance Rank of KALV is 2020
Overall Rank
The Sharpe Ratio Rank of KALV is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of KALV is 1818
Sortino Ratio Rank
The Omega Ratio Rank of KALV is 2121
Omega Ratio Rank
The Calmar Ratio Rank of KALV is 2525
Calmar Ratio Rank
The Martin Ratio Rank of KALV is 1616
Martin Ratio Rank

SMH
The Risk-Adjusted Performance Rank of SMH is 2929
Overall Rank
The Sharpe Ratio Rank of SMH is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of SMH is 2626
Sortino Ratio Rank
The Omega Ratio Rank of SMH is 2727
Omega Ratio Rank
The Calmar Ratio Rank of SMH is 4242
Calmar Ratio Rank
The Martin Ratio Rank of SMH is 2525
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KALV vs. SMH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for KalVista Pharmaceuticals, Inc. (KALV) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for KALV, currently valued at -0.53, compared to the broader market-2.000.002.004.00-0.530.74
The chart of Sortino ratio for KALV, currently valued at -0.53, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.531.16
The chart of Omega ratio for KALV, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.15
The chart of Calmar ratio for KALV, currently valued at -0.34, compared to the broader market0.002.004.006.00-0.341.07
The chart of Martin ratio for KALV, currently valued at -1.16, compared to the broader market0.0010.0020.0030.00-1.162.46
KALV
SMH

The current KALV Sharpe Ratio is -0.53, which is lower than the SMH Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of KALV and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.53
0.74
KALV
SMH

Dividends

KALV vs. SMH - Dividend Comparison

KALV has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.42%.


TTM20242023202220212020201920182017201620152014
KALV
KalVista Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMH
VanEck Vectors Semiconductor ETF
0.42%0.44%0.60%1.18%0.51%0.69%1.50%1.88%1.43%0.80%2.14%1.16%

Drawdowns

KALV vs. SMH - Drawdown Comparison

The maximum KALV drawdown since its inception was -96.68%, which is greater than SMH's maximum drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for KALV and SMH. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-92.27%
-8.50%
KALV
SMH

Volatility

KALV vs. SMH - Volatility Comparison

The current volatility for KalVista Pharmaceuticals, Inc. (KALV) is 11.23%, while VanEck Vectors Semiconductor ETF (SMH) has a volatility of 12.66%. This indicates that KALV experiences smaller price fluctuations and is considered to be less risky than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
11.23%
12.66%
KALV
SMH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab